| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DEVINCENZI ROBERT THOMAS | Director | 4225 E. WINDROSE DRIVE, SUITE 200, PHOENIX | /s/ Christopher Kevane, Attorney-in-Fact for Robert T. DeVincenzi | 14 Aug 2025 | 0001226186 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTI | Common Stock, $0.0001 par value | Purchase | $12,820 | +505 | +0.4% | $25.39 | 127,270 | 12 Aug 2025 | Direct | F1 |
| transaction | UTI | Common Stock, $0.0001 par value | Purchase | $241,171 | +9,495 | +7.5% | $25.40 | 136,765 | 12 Aug 2025 | Direct |
| Id | Content |
|---|---|
| F1 | The prices reported in Column 4 reflect a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.385 to $25.39. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. |